Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Women's Hormone Network (WHN) is a 501(c)3 non-profit organization dedicated to advancing women's health through the promotion of Physiologic Hormone Restoration Therapy (PHRT). The organization focuses on clinical research and education regarding bioidentical hormone replacement that mimics natural 28-day rhythmic cycles. WHN provides training for healthcare practitioners, certifies compounding pharmacies, and conducts clinical studies to validate its hormone restoration protocols. Their approach emphasizes using bioidentical hormones at physiologic levels and rhythmic timing to address symptoms of menopause and hormone-related decline. The network serves as a bridge between clinical research, medical practitioners, and patients seeking evidence-based hormone restoration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Women's Hormone Network.